Theratechnologies Inc. (TH) - Cash Flow Conversion Efficiency

Latest as of May 2025: -0.095x

Based on the latest financial reports, Theratechnologies Inc. (TH) has a cash flow conversion efficiency ratio of -0.095x as of May 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$2.66 Million ≈ $1.92 Million USD) by net assets (CA$-27.92 Million ≈ $-20.20 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Theratechnologies Inc. - Cash Flow Conversion Efficiency Trend (1996–2024)

This chart illustrates how Theratechnologies Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Theratechnologies Inc. balance sheet liabilities for a breakdown of total debt and financial obligations.

Theratechnologies Inc. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Theratechnologies Inc. ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Silver X Mining Corp
V:AGX
0.051x
Formuepleje Limittellus
CO:FPILIM
N/A
KB Star REIT Co. Ltd.
KO:432320
0.006x
EQL PHARMA AB
F:7JK
0.050x
Cardiol Therapeutics Inc Class A
TO:CRDL
-0.292x
SV Investment Corporation
KQ:289080
-0.034x
Sahamitr Pressure Container Public Company Limited
BK:SMPC
0.131x
TGE Value Creative Solutions Corp
NYSE:BEBE
0.019x

Annual Cash Flow Conversion Efficiency for Theratechnologies Inc. (1996–2024)

The table below shows the annual cash flow conversion efficiency of Theratechnologies Inc. from 1996 to 2024. For the full company profile with market capitalisation and key ratios, see TH market cap overview.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-11-30 CA$-25.27 Million
≈ $-18.28 Million
CA$2.38 Million
≈ $1.72 Million
-0.094x -134.60%
2023-11-30 CA$-20.87 Million
≈ $-15.10 Million
CA$-5.68 Million
≈ $-4.11 Million
0.272x -58.20%
2022-11-30 CA$-22.57 Million
≈ $-16.33 Million
CA$-14.69 Million
≈ $-10.63 Million
0.651x +179.85%
2021-11-30 CA$17.76 Million
≈ $12.85 Million
CA$-14.48 Million
≈ $-10.47 Million
-0.815x +80.61%
2020-11-30 CA$3.22 Million
≈ $2.33 Million
CA$-13.55 Million
≈ $-9.80 Million
-4.204x -2978.87%
2019-11-30 CA$24.83 Million
≈ $17.96 Million
CA$-3.39 Million
≈ $-2.45 Million
-0.137x -1331.40%
2018-11-30 CA$35.05 Million
≈ $25.36 Million
CA$-334.40K
≈ $-241.90K
-0.010x -116.76%
2017-11-30 CA$33.51 Million
≈ $24.24 Million
CA$1.91 Million
≈ $1.38 Million
0.057x -43.11%
2016-11-30 CA$20.02 Million
≈ $14.48 Million
CA$2.00 Million
≈ $1.45 Million
0.100x -71.72%
2015-11-30 CA$14.98 Million
≈ $10.83 Million
CA$5.30 Million
≈ $3.83 Million
0.354x +134.63%
2014-11-30 CA$6.87 Million
≈ $4.97 Million
CA$-7.02 Million
≈ $-5.08 Million
-1.022x -144.46%
2013-11-30 CA$17.45 Million
≈ $12.62 Million
CA$-7.29 Million
≈ $-5.28 Million
-0.418x +39.39%
2012-11-30 CA$22.82 Million
≈ $16.51 Million
CA$-15.74 Million
≈ $-11.39 Million
-0.690x +7.92%
2011-11-30 CA$35.20 Million
≈ $25.46 Million
CA$-26.36 Million
≈ $-19.07 Million
-0.749x -1459.83%
2010-11-30 CA$51.65 Million
≈ $37.36 Million
CA$2.84 Million
≈ $2.06 Million
0.055x -58.09%
2009-11-30 CA$40.70 Million
≈ $29.44 Million
CA$5.35 Million
≈ $3.87 Million
0.131x +114.60%
2008-11-30 CA$37.80 Million
≈ $27.35 Million
CA$-34.03 Million
≈ $-24.62 Million
-0.900x -83.28%
2007-11-30 CA$65.94 Million
≈ $47.70 Million
CA$-32.39 Million
≈ $-23.43 Million
-0.491x +5.50%
2006-11-30 CA$38.96 Million
≈ $28.18 Million
CA$-20.25 Million
≈ $-14.65 Million
-0.520x -487.37%
2005-11-30 CA$41.96 Million
≈ $30.35 Million
CA$-3.71 Million
≈ $-2.69 Million
-0.088x +74.68%
2004-11-30 CA$53.02 Million
≈ $38.35 Million
CA$-18.53 Million
≈ $-13.40 Million
-0.349x -6.85%
2003-11-30 CA$64.48 Million
≈ $46.65 Million
CA$-21.09 Million
≈ $-15.26 Million
-0.327x -72.10%
2002-11-30 CA$79.51 Million
≈ $57.52 Million
CA$-15.11 Million
≈ $-10.93 Million
-0.190x -58.13%
2001-11-30 CA$70.95 Million
≈ $51.32 Million
CA$-8.53 Million
≈ $-6.17 Million
-0.120x -1.33%
2000-11-30 CA$38.53 Million
≈ $27.87 Million
CA$-4.57 Million
≈ $-3.31 Million
-0.119x +40.93%
1999-11-30 CA$16.91 Million
≈ $12.23 Million
CA$-3.40 Million
≈ $-2.46 Million
-0.201x +38.66%
1998-11-30 CA$10.94 Million
≈ $7.91 Million
CA$-3.58 Million
≈ $-2.59 Million
-0.327x +35.81%
1997-11-30 CA$7.03 Million
≈ $5.08 Million
CA$-3.58 Million
≈ $-2.59 Million
-0.510x -102.72%
1996-11-30 CA$11.80 Million
≈ $8.54 Million
CA$-2.97 Million
≈ $-2.15 Million
-0.252x --

About Theratechnologies Inc.

TO:TH Canada Biotechnology
Market Cap
$148.68 Million
CA$205.53 Million CAD
Market Cap Rank
#17674 Global
#568 in Canada
Share Price
CA$4.47
Change (1 day)
-4.89%
52-Week Range
CA$3.20 - CA$4.70
All Time High
CA$58.28
About

Theratechnologies Inc., a biopharmaceutical company, focuses on the commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatm… Read more